Joy Gill Chair

Mr. Ajit S. Gill (BT/EE/1969) has set up the Joy Gill chair in honour of his parents. This chair is for a young faculty member in the department of Biological Science and Bioengineering. Mr. Gill joined USVP as an Entrepreneur-in-Residence in December 2006 after 14 years at Nektar Therapeutics (previously Inhale Therapeutic Systems) where he was the CEO for the last 8 years. He joined the company as CFO, soon after it received its Series-A financing in 1992, and also served as head of R&D and operations for several years. He led the development of Nektar's inhaled insulin product, Exubera, in partnership with Pfizer and Mr. Gill retired from Nektar when Exubera received regulatory approval from the FDA (US) and the EMEA (EU). During his time at Inhale/Nektar, Mr. Gill managed the transformation of the business model from a pulmonary delivery company, focussed on protein and peptide delivery, to a proprietary products company with several blockbuster products on the market incorporating its drug delivery technologies and a market cap of over $2 billion (fully diluted) when he stepped down as CEO. Prior to joining Inhale, Mr. Gill worked for many years in the computer business in a variety of roles in general management, finance, business development and operations. Immediately before joining Inhale, he was General Manager of Interactive Systems Products Business, a subsidiary of Eastman Kodak. Mr. Gill obtained his M.S. in electrical engineering from the University of Nebraska and his MBA from the University of Western Ontario.

Present Occupant (Prof. S. Ganesh)

          Report: 2011-2012

Professor S. Ganesh,
Department of Biological Sciences and Bioengineering is Joy Gill Chair Professor from November 2010 to November 2013. Prof. Ganesh was born on 23rd May, 1968 in Chittoor (AP). He did his PhD from Banaras Hindu University (BHU) in Varanasi. Prof. Ganesh joined the Department of Biological Sciences and Bioengineering (BSBE) at IIT-Kanpur in April 2002. Prof. Ganesh’s research interests are in the areas of molecular genetics of human disorders. His group works on the neurodegenerative disorders, a group of central nervous system dysfunctions characterised by the progressive loss of neural tissues, movement abnormalities, progressive decline in intellectual and cognitive functions, and in certain cases early death. A major research focus of Prof. Ganesh's group therefore is to identify and characterize molecular players in neurodegenerative pathways and to identify therapeutic targets. For this, he conducts genetic screens in affected families and utilize cellular/animal models for testing and validating the hypothesis. Discovery of critical players in neurodegeneration is undoubtedly the first step towards developing effective therapeutics. Prof. Ganesh is a recipient of several awards including the Rajib Goyal Prize in Life Sciences (Goyal Foundation, Kurukshetra University), DAE-SRC Outstanding Research Investigator Award (Dept. of Atomic Energy, Govt. of India), B.M. Birla Science Prize in Biology (BM. Birla Science Centre, Hyderabad), National Bioscience Award for Career Development (Dept. of Biotechnology, Govt. of India) and the Scopus Young Scientist Award in Biological Sciences (Elsevier India).


Past Occupant- R. Sankararamakrishnan (BSBE), June 2007 to June 2010.